INO vs POOL · rev $65.3K vs P/E 18, rev $5.31B
Inovio Pharmaceuticals Inc (INO) versus Pool Corporation (POOL) — a side-by-side from cached financials, not a winner call.
Inovio Pharmaceuticals Inc (INO) is a biotechnology company listed on US.
Pool Corporation (POOL) is a industrial distribution company listed on NASDAQ.
Latest reported INO revenue for 2025-12-31 was $65.3K. Net income was -$84.9M. Revenue was down 70.0% from 2024-12-31 to 2025-12-31. INO currently screens at market cap $88.0M.
Latest reported POOL revenue for 2024-12-31 was $5.31B. Net income was $434.3M. Revenue was up 429.5% from 2023-12-31 to 2024-12-31. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
INO currently screens at market cap $88.0M. POOL currently screens at market cap $7.08B and trailing P/E 17.9.
Not investment advice. Open the INO and POOL stock pages for the full models.
Not investment advice.